On August 24, 2023, Tango Therapeutics, Inc. closed the transaction. The company amended the terms of the transaction and received gross proceeds of $80,016,604. The transaction included participation from 17 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.77 USD | -1.77% | +2.37% | -21.52% |
08/05 | Tango Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04/04 | British billionaire Joe Lewis fined $5 million by US judge for insider trading | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.52% | 830M | |
+23.37% | 47.02B | |
+50.07% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- TNGX Stock
- News Tango Therapeutics, Inc.
- Tango Therapeutics, Inc. announced that it has received $80.016604 million in funding